Urgent

Cardiac amyloidosis decompensation

Restrictive infiltrative failure · Cardiac
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Amyloid deposition causing restrictive cardiomyopathy with heart failure, conduction disease and sensitivity to preload changes.

Red flags

  • Hypotension with diuretics
  • Syncope
  • Complete heart block
  • Intracardiac thrombus

Assessment

Differential diagnosis

  • Hypertrophic cardiomyopathy
  • Constrictive pericarditis
  • Hypertensive heart disease
  • Cardiac sarcoid
  • Fabry disease

Investigations

  • ECG (low voltage with LVH on echo)
  • Echocardiography (thick walls, sparkling myocardium)
  • Cardiac MRI, serum/urine light chains
  • NT-proBNP and troponin

Management

  • Cautious diuresis for congestion, avoiding hypotension
  • Avoid preload-dependent hypotension and overdiuresis
  • Use rate control cautiously; digoxin binds amyloid and is generally avoided
  • Treat arrhythmia and consider anticoagulation for AF
  • Screen for and treat underlying plasma cell dyscrasia
  • Refer to specialist amyloid service

Drugs & doses

Loop diuretic (furosemide) - titrated for congestion
Anticoagulant (e.g. DOAC) - for AF given high thrombus risk
Avoid digoxin, CCBs and beta-blockers where poorly tolerated

Disposition

Admit for decompensation; refer to amyloidosis specialist centre.

Complications & pitfalls

  • Refractory heart failure
  • Atrial thrombus/embolism
  • Conduction block and sudden death

Exam pearls

  • Discordant low ECG voltage with thick walls is a clue
  • These patients are exquisitely preload-sensitive
  • Digoxin and CCBs can accumulate and are usually avoided

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.